Solventum (SOLV) earnings per share (EPS)
Solventum (SOLV) reported diluted earnings per share of $8.88 in fiscal 2025 (the year ended December 31, 2025). That is 221.7% higher than the $2.76 of fiscal 2024. Figures as of 17 Nov 2026, 22:19 UTC, from Yahoo Finance.
Key facts
- Earnings per share, fiscal 2025
- $8.88
- Change on fiscal 2024
- +221.7%
- Highest on record
- $8.88fiscal 2025
- Lowest on record
- $2.76fiscal 2024
- Fiscal years on record
- 42022–2025
Figures as of . Statements from Yahoo Finance. Amounts are in USD. Figures, not advice.
Solventum earnings per share (EPS), in more detail
Across the 4 fiscal years on record (2022–2025), the highest was $8.88 in fiscal 2025 and the lowest $2.76 in fiscal 2024.
Earnings per share by fiscal year
Solventum earnings per share (EPS), year by year
| Fiscal year | Earnings per share | Change | Year ended |
|---|---|---|---|
| 2025 | $8.88 | 221.7% up | |
| 2024 | $2.76 | 64.6% down | |
| 2023 | $7.79 | 0.2% up | |
| 2022 | $7.78 | — |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.
How to read it
It shows how much profit stands behind each share, so it rises when profit grows or when buybacks shrink the share count.
Earnings per share at health care companies of similar size
| Company | Earnings per share | Fiscal year |
|---|---|---|
| Ascendis Pharma ASND | -€3.76 | 2025 |
| ICON ICLR | $2.71 | 2025 |
| Jazz Pharmaceuticals JAZZ | -$5.84 | 2025 |
| Solventum SOLV | $8.88 | 2025 |
| BridgeBio Pharma BBIO | -$3.78 | 2025 |
| Summit Therapeutics SMMT | -$1.44 | 2025 |
The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.
Solventum, figure by figure
- Solventum market cap
- Solventum revenue
- Solventum earnings
- Solventum P/E ratio
- Solventum P/S ratio
- Solventum P/B ratio
- Solventum free cash flow
- Solventum operating margin
- Solventum dividend
- Solventum shares outstanding
- Solventum total debt
- Solventum cash on hand
- Solventum total assets
- Solventum return on equity (ROE)
- Solventum return on invested capital (ROIC)
Solventum (SOLV) overview: price, valuation and scorecardAll health care companies by market value
Solventum earnings per share (EPS): questions and answers
What is Solventum's diluted earnings per share?
Solventum (SOLV) reported diluted earnings per share of $8.88 in fiscal 2025 (the year ended December 31, 2025). That is 221.7% higher than the $2.76 of fiscal 2024.
What are the highest and lowest diluted earnings per share figures on record for Solventum?
Across the 4 fiscal years on record (2022–2025), the highest was $8.88 in fiscal 2025 and the lowest $2.76 in fiscal 2024.
How is Solventum's diluted earnings per share calculated?
Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.
Fiscal years are named for the calendar year they end in.
Learn: earnings per share (EPS)
All stocks guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
Cite this page
Funkfolio, “Solventum (SOLV) earnings per share (EPS)”, data as of 17 November 2026. https://funkfolio.com/stock/SOLV/eps
Underlying data: Yahoo Finance.